Andropause and Metabolic Syndrome


Declining testosterone levels are commonly seen in men beginning in the fourth decade of life. Suboptimal or low testosterone levels in males are often associated with symptoms of aging and are referred to as andropause or male menopause.

This is the equivalent of menopause in women when ovarian production of estrogens and progesterone begins to decline.  


Testosterone is an important anabolic hormone in men, meaning it plays important roles in maintaining both physical and mental health.

It increases energy, prevents fatigue, helps maintain normal sex drive, increases strength of all structural tissues such as skin/bone/muscle; including the heart and prevents depression and mental fatigue.  


Testosterone deficiency is often associated with symptoms such as night sweats, insulin resistance, erectile dysfunction, low sex drive, decreased mental and physical ability, lower ambition, loss of muscle mass and weight gain in the waist.

The primary cause of this increase in girth is visceral fat, not excessive subcutaneous fat (fat under the skin).  


The visceral fat cells are the most insulin resistant cells in the human body.

They have excess hormone binding receptors for cortisol and androgens and decreased receptors for insulin (resistance to insulin).

As a person ages hormone levels change in favor of insulin resistance.  


The cortisol and insulin levels rise while progesterone, growth hormone and testosterone decline. The visceral fat cell with its increased receptors, blood supply and innervation begins to collect more fat in the form of triglycerides.

A vicious cycle is initiated, which if not interrupted with natural hormone
balancing will lead to abdominal obesity, diabetes and high cholesterol levels.

This phenomenon is known as metabolic syndrome.  


Stress management, exercise, proper nutrition, dietary supplements (particularly adequate zinc and selenium), and androgen replacement therapy (controversial in prostate cancer) have all been shown to raise androgen levels in men and help counter andropause symptoms.

The “trick" is to know how much testosterone is required for each individual male.  


This is where knowing the salivary testosterone levels comes into play.

Initial salivary testing and following salivary monitoring are crucial for determining the most optimal prescription.  


Prior to initiation of testosterone therapy the PSA level needs to be within the expected range. There is no evidence that testosterone increases the risk of prostate gland cancer; however, if cancer has already developed testosterone may accelerate its growth.  


The PSA test is a good guide as to presence or absence of cancer and is a good indicator of inflammation within the prostate gland.